STAT1 and cancer: The results of these assays confirmed that the mutated RNase1 lost its ability to inhibit T‐cell cytotoxicity against cancer cells (Figure 6N), supporting that disrupting the RNase1‐STAT1 interaction may prevent RNase1‐induced T‐cell dysfunction.